Literature DB >> 1610830

Mechanism of inhibition of the class C beta-lactamase of Enterobacter cloacae P99 by phosphonate monoesters.

J Rahil1, R F Pratt.   

Abstract

The class C serine beta-lactamase of Enterobacter cloacae P99 was inhibited by a series of aryl methylphosphonate monoester monoanions. The effectiveness of these inhibitors was promoted by an acylamido substituent on the methyl group and a good leaving group at phosphorus. The former preference suggests that noncovalent interaction of these inhibitors with the enzyme resembles that of substrates, while the latter suggests that nucleophilic displacement at phosphorus occurs as part of the inhibition mechanism. The truth of the latter proposition was confirmed by observation of release of 1 equiv of phenol concomitant with inhibition and of the presence of an equivalent amount of 14C-label on the enzyme after inhibition by a 14C-labeled phosphonate. The hydrolytically inert nature of the enzyme-inhibitor adduct, and its 31P chemical shift, suggested that O-phosphonylation of the enzyme had occurred. Although, by analogy with substrates, one might expect that the hydroxyl of the active site serine residue would be covalently modified by these inhibitors, successive alkali and acid treatment of the enzyme-inhibitor adduct generated no pyruvate. Instead, 1 equiv of lysinoalanine was found. This product was rationalized to arise through intramolecular capture by an adjacent lysine amine group of the dehydroalanine residue produced by alkali treatment of an O-phosphonylated serine residue. One equivalent of lysinoalanine was also produced by alkali treatment of the enzyme that had been inhibited by 6 beta-bromopenicillanic acid, a mechanism-based inhibitor known to acylate the hydroxyl group of the active site serine residue. It is therefore likely that the aryl phosphonates phosphonylate this residue. These compounds should be useful as beta-lactamase active site titrants and as sources of fresh insight into the chemical properties of the active site. The significant mechanistic features of the inhibition, in particular its strong leaving group dependence and the distinctive ability of the beta-lactamase active site to stabilize a dianionic transition state containing a pentacoordinated phosphorus, are discussed with respect to the active site structure. The comparison with phosph(or/on)yl inhibitors of serine proteinases is made, and the mechanism-based features of inhibition of serine hydrolases by phosph(on)ates are noted.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1610830     DOI: 10.1021/bi00140a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Inhibition of class D beta-lactamases by acyl phosphates and phosphonates.

Authors:  S A Adediran; Michiyoshi Nukaga; Stéphane Baurin; J-M Frère; R F Pratt
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 2.  Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.

Authors:  Carine Bebrone; Patricia Lassaux; Lionel Vercheval; Jean-Sébastien Sohier; Adrien Jehaes; Eric Sauvage; Moreno Galleni
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

3.  Reaction of soluble penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus with beta-lactams and acyclic substrates: kinetics in homogeneous solution.

Authors:  K Graves-Woodward; R F Pratt
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

4.  Inhibition of DD-peptidases by a specific trifluoroketone: crystal structure of a complex with the Actinomadura R39 DD-peptidase.

Authors:  Liudmila Dzhekieva; S A Adediran; Raphael Herman; Frédéric Kerff; Colette Duez; Paulette Charlier; Eric Sauvage; R F Pratt
Journal:  Biochemistry       Date:  2013-03-13       Impact factor: 3.162

5.  Substituted aryl malonamates as new serine beta-lactamase substrates: structure-activity studies.

Authors:  S A Adediran; D Cabaret; J-F Lohier; M Wakselman; R F Pratt
Journal:  Bioorg Med Chem       Date:  2009-10-31       Impact factor: 3.641

6.  Structure-activity relationships in the inhibition of serine beta-lactamases by phosphonic acid derivatives.

Authors:  J Rahil; R F Pratt
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

7.  Inhibition of chymotrypsin by a complex of ortho-vanadate and benzohydroxamic acid: structure of the inert complex and its mechanistic interpretation.

Authors:  Aaron Moulin; Jason H Bell; R F Pratt; Dagmar Ringe
Journal:  Biochemistry       Date:  2007-05-01       Impact factor: 3.162

8.  Kinetics and mechanism of inhibition of a serine beta-lactamase by O-aryloxycarbonyl hydroxamates.

Authors:  Ryan B Pelto; R F Pratt
Journal:  Biochemistry       Date:  2008-10-23       Impact factor: 3.162

9.  Inhibition of class A and C beta-lactamases by diaroyl phosphates.

Authors:  Sudipta Majumdar; R F Pratt
Journal:  Biochemistry       Date:  2009-09-08       Impact factor: 3.162

10.  Detection of an enzyme isomechanism by means of the kinetics of covalent inhibition.

Authors:  S A Adediran; Michael J Morrison; R F Pratt
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2021-06-02       Impact factor: 4.125

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.